Karyopharm Therapeutics Inc. (KPTI) Insider Trading -- Recent Executive & Director Transactions
13 insiders reported 63 Form 4 transactions for Karyopharm Therapeutics Inc. (KPTI) over the past 18 months (most recent 2026-10-02). Recent activity: Abate Kristin (Chief Accounting Officer) Sell 378 shares, Abate Kristin (Chief Accounting Officer) Sell 19 shares, Poulton Stuart (EVP, Chief Development Officer) Sell 189 shares, PAKIANATHAN DEEPIKA (Director) Buy 15,508 shares, BOHLIN GAREN G (Director) Buy 15,508 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-02 | Abate Kristin | Chief Accounting Officer | Sell | 378 | $450 |
| 2026-09-02 | Abate Kristin | Chief Accounting Officer | Sell | 19 | $38 |
| 2026-07-30 | Poulton Stuart | EVP, Chief Development Officer | Sell | 189 | $1,342 |
| 2026-05-26 | PAKIANATHAN DEEPIKA | Director | Buy | 15,508 | $0 |
| 2026-05-26 | BOHLIN GAREN G | Director | Buy | 15,508 | $0 |
| 2026-05-26 | Oliger Christy J. | Director | Buy | 15,508 | $0 |
| 2026-05-26 | Schor Chen | Director | Buy | 15,508 | $0 |
| 2026-05-26 | Su Zhen | Director | Buy | 15,508 | $0 |
| 2026-05-26 | Greene Barry E | Director | Buy | 15,508 | $0 |
| 2026-05-15 | Rangwala Reshma | EVP & Chief Medical Officer | Sell | 408 | $3,876 |
| 2026-05-15 | Poulton Stuart | EVP, Chief Development Officer | Sell | 403 | $3,828 |
| 2026-05-15 | Rangwala Reshma | EVP & Chief Medical Officer | Buy | 947 | $0 |
| 2026-05-15 | Poulton Stuart | EVP, Chief Development Officer | Buy | 896 | $0 |
| 2026-05-15 | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | Buy | 947 | $0 |
| 2026-05-15 | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | Sell | 324 | $3,078 |
| 2026-05-15 | Paulson Richard A. | President and CEO | Buy | 4,920 | $0 |
| 2026-05-15 | Paulson Richard A. | President and CEO | Sell | 2,203 | $20,928 |
| 2026-05-15 | Mano Michael | EVP, CLO&Secretary | Buy | 700 | $0 |
| 2026-05-15 | Mano Michael | EVP, CLO&Secretary | Sell | 266 | $2,527 |
| 2026-05-15 | Abate Kristin | Chief Accounting Officer | Buy | 121 | $0 |
| 2026-05-15 | Abate Kristin | Chief Accounting Officer | Sell | 53 | $504 |
| 2026-04-22 | Rangwala Reshma | EVP & Chief Medical Officer | Sell | 449 | $4,014 |
| 2026-03-03 | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | Sell | 4,604 | $43,324 |
| 2026-03-03 | Rangwala Reshma | EVP & Chief Medical Officer | Sell | 5,066 | $47,671 |
| 2026-03-03 | Abate Kristin | Chief Accounting Officer | Sell | 559 | $5,260 |
Source: SEC Form 4 filings · as of 2026-10-02